Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

5.22
Delayed Data
As of Dec 09
 -0.32 / -5.78%
Today’s Change
2.50
Today|||52-Week Range
6.35
-7.94%
Year-to-Date
Luminex Corporation (LMNX): Are Hedge Funds Right About This Stock?
Dec 08 / Investing Channel - Paid Partner Content
2 Red-Hot Biotechs to Buy Ahead of FDA Decisions
Nov 29 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close5.54
Today’s open6.24
Day’s range5.04 - 6.29
Volume20,300,318
Average volume (3 months)3,079,274
Market cap$939.4M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-8.82%
Earnings growth (this year)+9.24%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc-0.07-0.26%
CORTCorcept Therapeutics...+0.37+4.68%
AMPHAmphastar Pharmaceut...-0.23-1.15%
LCILannett Company Inc+0.25+1.04%
Data as of 4:14pm ET, 12/09/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$117.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Gary S. Jacob
Senior Vice President-
Clinical Operations
Laura Barrow
Corporate headquarters
New York, New York

Forecasts


Search for Jobs